Market Research Logo

Artificial Organs

Artificial Organs

This report analyzes the worldwide markets for Artificial Organs in US$ Million by the following Product Segments: Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas, and Artificial Lungs. The report provides separate comprehensive analytics for the US, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as -

 ABBOTT
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
F.Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Artificial Organs
Artificial Heart
Artificial Kidneys
Artificial Liver
Artificial Pancreas
Artificial Lungs
2. INDUSTRY OVERVIEW
Artificial Organs Revolutionize Medical Industry
Growth Drivers
Growth Inhibitors
Artificial Organs Poised to Witness Significant Demand
The United States – A Dominant Force in the Artificial Organs Market
Artificial Kidneys Garner a Larger Pie in the Artificial Organs Market
Demand and Supply Imbalance
Table 1: Total Number of Donors, Transplants, and Waiting List in the US: 2001-2017 (includes corresponding Graph/Chart)
Table 2: Total Number of People on the Waiting List for Organ Transplantation in the US by Type: 2018 (includes corresponding Graph/Chart)
Competitive Scenario
Technological Advancements Spearheading Growth
3. ANALYSIS BY SEGMENT
Artificial Heart
Medical Community Poised to Embrace Artificial Heart
Ventricular Assist Devices
Select Ventricular Assist Devices
Artificial Mechanical Heart Valves Come of Age
Artificial Kidney
Kidney Failure: A Major Concern
Artificial Kidney or Dialyzers Market
Major Initiatives in the Artificial Kidney Space
The Kidney Project
Current Status of the Kidney Project
Artificial Kidney Likely to Begin Human Trials by 2019
Wearable Artificial Kidney May be Boon to Dialysis Patients
Artificial Liver
Bioartificial Liver Innovation Shows Potential to Avoid Transplants
Types of Liver Support Devices
Artificial Pancreas
Artificial Pancreas Device System Market Presents Lucrative Opportunities
Market Overview
Scientific Community Inches towards Artificial Pancreas System
Competition and Key Developments in Artificial Pancreas Space
Bionic Pancreas System
Types of Artificial Pancreas Delivery Systems and FDA’s Efforts for their Development
Researchers Develop Improvised Artificial Lungs Prototype with Vasculature
Crucial Artificial Lung Trial Enrolls Record Number of Patients
Lightweight and Portable Artificial Lung Innovations
4. MARKET TRENDS AND ISSUES
Increasing Incidence of Cardiovascular Disease Drive the Market for Artificial Heart and VAD
Table 3: Prevalence of Heart Failure in Select Countries
Higher Development Costs and Lengthy Regulatory Process – Stumbling Blocks for Product Commercialization
Lack of Requisite Expertise – Hindering Implantation Process
Xenotransplantation – Other Alternative to Donor Organ Shortage
Artificial Organs from Cloned Animal Cells – A Promising Trend
Immunosuppressants Hold Promise in Artificial Organs Market
Move towards Smaller Implantable Devices
Barriers to Entry Significantly High in Dialyzers Market
Reuse of Dialyzers – A Major Issue in Dialysis Industry
Poor Reimbursement Environment Stymies Innovation
Product Recalls – A Major Blow to the Manufacturers
Higher Cost of Artificial Organs Hampers Broader Adoption
Major Issues Related to Artificial Organs
Financial
Legal
Ethical
Social
5. MACRO FACTORS IMPACTING THE ARTIFICIAL ORGANS MARKET
Aging Population: A Strong Growth Driver
Global Aging Population Statistics – Opportunity Indicators
Table 4: Global Population Statistics for 65+ Age Group (Male & Female) for Major Countries/ Regions (mid-2016) (includes corresponding Graph/Chart)
Table 5: Life Expectancy for Select Countries in Number of Years: 2015 (includes corresponding Graph/Chart)
Expanding Pool of ESRD and CKD Patients – The Major Growth Driver for Kidney Dialysis Treatment
Table 6: Increasing Number of ESRD Patients Worldwide: 2015-2024 (includes corresponding Graph/Chart)
Dialysis Market to Stage Steady Growth Amid Rising Prevalence of Kidney Diseases
Table 7: Global Population of ESRD Patients Undergoing Treatment by Type of Modality (2010, 2015 & 2020): Percentage Breakdown of Patients Undergoing Dialysis Therapy, and Kidney Transplantation (includes corresponding Graph/Chart)
Distribution of Dialysis Patients by Modality
Table 8: Global Population of ESRD Patients Undergoing Therapy by Type of Treatment (2016): Percentage Breakdown of Patients Receiving Hemodialysis, Kidney Transplants, and Peritoneal Dialysis (includes corresponding Graph/Chart)
Table 9: Global Dialysis Patient Population Distribution by Modality for Select Countries (2016): Percentage Breakdown of Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients for US, China, Japan, Brazil, Mexico, Germany, India, Taiwan, Turkey, Thailand, Korea, Italy, France, Egypt and Malaysia (includes corresponding Graph/Chart)
Developed Markets Maintain Lead, Emerging Markets to Dictate Momentum
Table 10: Global Dialysis Patient Population by Geographic Region/Country (2017E & 2024P): Percentage Breakdown of Patient Population for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World (includes corresponding Graph/Chart)
Rising Incidence of Diabetes: Opportunity Indicator for Artificial Pancreas
Table 11: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045 (includes corresponding Graph/Chart)
Table 12: Global Prevalence (%) of Diabetes in Adults (20-79) by Region for the Years 2017 and 2045 (includes corresponding Graph/Chart)
Table 13: Global Prevalence of Diabetes - Number of Adults Diagnosed with Diabetes (in Million) by Gender for the Year 2017 (includes corresponding Graph/Chart)
Table 14: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender for the Year 2017 (includes corresponding Graph/Chart)
Table 15: Diabetes Prevalence in Rural and Urban Areas - Number of Adults with Diagnosed Diabetes (in Million) in Urban and Rural Areas for 2017 and 2045 (includes corresponding Graph/Chart)
Table 16: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2017 and 2045 (includes corresponding Graph/Chart)
Table 17: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region for the Year 2017 (includes corresponding Graph/Chart)
Growing Number of Type 1 Diabetes Cases in Children
Table 18: Global Prevalence of Type 1 Diabetes in Children by Region (2017) (includes corresponding Graph/Chart)
Table 19: Top 10 Countries for Number of Children with Type 1 Diabetes (2017) (includes corresponding Graph/Chart)
6. 3D BIOPRINTING – A GAME CHANGER FOR THE ARTIFICIAL ORGANS INDUSTRY
Application of 3D-Printing in the Medical Field
3D Printing Revolutionizing the Medical Industry’s Artificial Organ Development Segment
“Soft” 3D Bioprinting Eliminates Concerns of Hard Plastic-based Organ Models
3D Printed Organ Models with Sensors Enable Real-time Feedback…
7. TECHNOLOGICAL ADVANCEMENTS
UCLA Researchers Develop Cancer-Fighting Cells
Production of 3D-like Artificial Organs in a Device that Works like a Cotton Candy Machine
Harvard Scientists Create Tissue Containing Blood Vessels
University of Washington Researchers Create Communicating Yeast Cells
Scientists Define Morphospace to Evaluate Viability of Artificial Organs
8. PRODUCT OVERVIEW
Artificial Organs
Categorization of Artificial Organs
External Artificial Organs
Internal or Implantable Artificial Devices
Artificial Heart
Total Artificial Heart (TAH)
Ventricle Assist Device (VAD)
Table 20: Distribution of Various Uses of VADs (includes corresponding Graph/Chart)
Right Ventricular Assist Systems (RVAS)
Left Ventricular Assist Systems (LVAS)
Categorization of LVAS
First Generation LVAS
Second Generation LVAS
Third Generation LVAS
Benefits of LVAS
Major Limitations and Complications of VADs
Infection
Internal Bleeding
Thrombus
Dependability
Cost
Natural Human Heart
Heart Diseases
Congenital Heart Disease
Congestive Heart Failure
Types of Heart Failure
Diastolic Heart Failure
Systolic Heart Failure
Artificial Heart – A Historical Perspective
Major Milestones in Artificial Heart Development
Jarvik-7
AbioCor Total Artificial Heart
CardioWest Temporary Total Artificial Heart
DuraHeart LVAS
HeartSaverVAD
VentrAssist Left Ventricular Assist Device
Artificial Kidney (Dialyzer)
Limitations of Artificial Kidney
Types of Dialysis
Hemodialysis
Peritoneal Dialysis
Advancements in Artificial Kidney Technology
Bioartificial Kidneys
Limitations of Bioartificial Kidneys
Hindrances to Develop Implantable Artificial Kidney
Artificial Kidneys – A Historical Perspective
Artificial Liver
Overdose of Drugs – A Leading Cause for Liver Damage
Categorization of Liver Devices
Mechanical Systems
Liver Dialysis Unit™
Bio-Artificial Systems
Capillary Hollow Fiber Systems
Direct Perfusion Systems
Entrapment Based Systems
Major BAL Devices
Extracorporeal Liver Assist Device (ELAD)
Cellular Components
Types of Bioreactor
Hybrid Artificial Liver Support System
History of Artificial Liver
Liver Assist Devices – Major Milestones
Nonbiological Method Introduction Time Line
Biological Method Introduction Time Line
Artificial Pancreas
Insulin Pumps – Historical Perspective
Bioartificial Pancreas
Nanotechnology in Artificial Pancreas
Artificial Lungs (Oxygenator)
About Human Lungs
Types of Artificial Lung
Intravenous Membrane Oxygenator
Hattler Respiratory Catheter
MC3 Pulmonary Assist Device
In-Series
In-Parallel
BioLung
Heart-Lung Bypass Machine
Role of Artificial Lungs during Surgery
Direct Contact Device
Indirect-Contact Type-Membrane Devices
Biorubber to be used in Artificial Lungs
History of Artificial Lungs
An Overview of Tissue Engineering
9. REGULATORY ENVIRONMENT
Regulatory Environment in the US
Regulatory Environment in Europe
10. COMPETITIVE LANDSCAPE
10.1 Focus on Select Global Players
ABBOTT (USA)
Abiomed, Inc. (USA)
Asahi Kasei Medical Co., Ltd. (Japan)
Baxter International, Inc. (USA)
F.Hoffmann-La Roche Ltd. (Switzerland)
Fresenius Medical Care AG & Co. KGaA (Germany)
Jarvik Heart, Inc. (USA)
Medtronic, Inc. (USA)
HeartWare International, Inc. (USA)
Nikkiso Co., Ltd. (Japan)
Nipro Corporation (Japan)
SynCardia Systems, LLC (USA)
Toray Medical Co., Ltd. (Japan)
Xenios AG (Germany)
10.2 Recent Industry Activity
Vital Therapies Reports the Failure of ELAD System in Phase III Trial
A Ten-Year-Old Becomes the Youngest Patient to Receive 50CC Temporary TAH
Tandem Diabetes Care Secures FDA Approval for Closed-loop Insulin System
ALung Registers Record Enrollment for the Pivotal Trial of Artificial Lung Technology
Automated Insulin Delivery and Monitoring System Receives FDA Approval for Use in Younger Pediatric Patients
Artificial Lung Rises Hope for Future Transplant Patients
Medtronic Introduces ‘Artificial Pancreas’ Hybrid Closed Loop System in the U.S.
Johnson & Johnson Exits Insulin Pump Business
B. Braun Introduces New Dialyzer
Versa Ventures Acquires Syncardia
Medtronic and HeartWare International Ink Merger Agreement
Vivonics Sells Artificial Lung Technology to Lung Biotechnology PBC
Insulet Corporation Enters into a Partnership and License Agreement with Mode AGC
Cellnovo Group Enters into a Partnership with TypeZero
Medtronic Launches MiniMed(TM) 640G System
Pandorum Develops Artificial Human Liver Tissue
11. GLOBAL MARKET PERSPECTIVE
Table 21: World Recent Past, Current & Future Analysis for Artificial Organs by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Artificial Organs by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 23: World 14-Year Perspective for Artificial Organs by Geographic Region - Percentage Breakdown of Dollar Sales for US and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
Table 24: World Recent Past, Current & Future Analysis for Artificial Organs by Product Segment - Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas and Artificial Lungs Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 25: World Historic Review for Artificial Organs by Product Segment - Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas and Artificial Lungs Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 26: World 14-Year Perspective for Artificial Organs by Product Segment - Percentage Breakdown of Dollar Sales for Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas and Artificial Lungs Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
Table 27: World Recent Past, Current & Future Analysis for Artificial Kidneys/ Dialyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa, and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 28: World Historic Review for Artificial Kidneys/Dialyzers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa, and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 29: World 14-Year Perspective for Artificial Kidneys/Dialyzers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East & Africa, and Latin American Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
Table 30: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 31: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 32: World 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)
12. REGIONAL MARKET PERSPECTIVE
12.1 The United States
A. Market Analysis
SynCardia’s temporary Total Artificial Heart: The Only FDA Approved Artificial Heart
Ageing Demographics: A Major Driving Factor for Artificial Organs Market
Table 33: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Dialysis Patient Population- An Opportunity Indicator for Artificial Kidneys
Table 34: Dialysis Patient Population in the US (2015-2024) (includes corresponding Graph/Chart)
Table 35: US Dialysis Patient Population by Modality (2016) (includes corresponding Graph/Chart)
Single Use Dialyzers Gain Traction
Diabetes: A Key Growth Driver
Table 36: Diabetes and Population Statistics in North America and Caribbean Region (2017 & 2045) (includes corresponding Graph/Chart)
Table 37: Diabetes Statistics in the US (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (‘000s), and Number of Diabetes-Related Deaths (in ‘000s)
B. Market Analytics
Table 38: The US Recent Past, Current & Future Analysis for Artificial Organs Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 39: The US Historic Review for Artificial Organs Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
12.2 Rest of World
A. Market Analysis
Table 40: Diabetes and Population Statistics in Europe (2017 & 2045) (includes corresponding Graph/Chart)
Table 41: Diabetes Statistics in Europe (2017) - Adults with Diabetes (20-79) in 1,000s, Diabetes Age-Adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) in 1,000s, and Diabetes Related Deaths (20-79 years) for Select Countries (includes corresponding Graph/Chart)
Table 42: Diabetes Statistics in Western Pacific (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Table 43: Diabetes Statistics in South East Asia (2017) - Number of Adults with Diabetes (20-79) (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes ('000s) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Table 44: Diabetes Statistics in South & Central America (2017) - Number of Adults with Diabetes (20-79 (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Table 45: Diabetes Statistics in Africa (2017) - Number of Adults (20-79) with Diabetes (in ‘000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed Diabetes (20-79) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
Table 46: Diabetes Statistics in Middle East and North Africa for 2017 and 2045 (includes corresponding Graph/Chart)
Table 47: Diabetes Statistics in Middle East and North Africa (2017) - Number of Adults with Diabetes (in 000s), Diabetes age-adjusted (20-79) Comparative Prevalence (%), Adults with Undiagnosed diabetes (20-79) ('000s), and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)
B. Market Analytics
Table 48: Rest of World Recent Past, Current & Future Analysis for Artificial Organs Market Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 49: Rest of World Historic Review for Artificial Organs Market Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)
13. COMPANY PROFILES 124 Total Companies Profiled: 42 (including Divisions/Subsidiaries - 47)
The United States (20)
Japan (8)
Europe (13)
- France (2)
- Germany (4)
- The United Kingdom (2)
- Rest of Europe (5)
Asia-Pacific (Excluding Japan) (4)
Middle East (2)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report